Effects of Matrix Metalloproteinase-9 Gene Knock-Out on the Proteolysis of Blood–Brain Barrier and White Matter Components after Cerebral Ischemia

Deleterious processes of extracellular proteolysis may contribute to the progression of tissue damage after acute brain injury. We recently showed that matrix metalloproteinase-9 (MMP-9) knock-out mice were protected against ischemic and traumatic brain injury. In this study, we examined the mechanisms involved by focusing on relevant MMP-9 substrates in blood–brain barrier, matrix, and white matter. MMP-9 knock-out and wild-type mice were subjected to transient focal ischemia. MMP-9 levels increased after ischemia in wild-type brain, with expression primarily present in vascular endothelium. Western blots showed that the blood–brain barrier-associated protein and MMP-9 substrate zonae occludens-1 was degraded after ischemia, but this was reduced in knock-out mice. There were no detectable changes in another blood–brain barrier-associated protein, occludin. Correspondingly, blood–brain barrier disruption assessed via Evans Blue leakage was significantly attenuated in MMP-9 knock-out mice compared with wild types. In white matter, ischemic degradation of the MMP-9 substrate myelin basic protein was significantly reduced in knock-out mice compared with wild types, whereas there was no degradation of other myelin proteins that are not MMP substrates (proteolipid protein and DM20). There were no detectable changes in the ubiquitous structural protein actin or the extracellular matrix protein laminin. Finally, 24 hr lesion volumes were significantly reduced in knock-out mice compared with wild types. These data demonstrate that the protective effects of MMP-9 gene knock-out after transient focal ischemia may be mediated by reduced proteolytic degradation of critical blood–brain barrier and white matter components.

[1]  A. Gearing,et al.  Immunohistochemistry of matrix metalloproteinases in reperfusion injury to rat brain: activation of MMP-9 linked to stromelysin-1 and microglia in cell cultures , 2001, Brain Research.

[2]  M. Fini,et al.  Role for Matrix Metalloproteinase 9 after Focal Cerebral Ischemia: Effects of Gene Knockout and Enzyme Inhibition with BB-94 , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[3]  P. Gottschall,et al.  Regional and age-related expression of gelatinases in the brains of young and old rats after treatment with kainic acid , 2000, Neuroscience Letters.

[4]  P. Lapchak,et al.  Metalloproteinase Inhibition Reduces Thrombolytic (Tissue Plasminogen Activator)–Induced Hemorrhage After Thromboembolic Stroke , 2000, Stroke.

[5]  M. Fini,et al.  Effects of Matrix Metalloproteinase-9 Gene Knock-Out on Morphological and Motor Outcomes after Traumatic Brain Injury , 2000, The Journal of Neuroscience.

[6]  S. Traynelis,et al.  Serine proteases and brain damage – is there a link? , 2000, Trends in Neurosciences.

[7]  T. Ferguson,et al.  MMP-2 and MMP-9 Increase the Neurite-Promoting Potential of Schwann Cell Basal Laminae and Are Upregulated in Degenerated Nerve , 2000, Molecular and Cellular Neuroscience.

[8]  T. Betsuyaku,et al.  Gelatinase B is required for alveolar bronchiolization after intratracheal bleomycin. , 2000, The American journal of pathology.

[9]  H. Hartung,et al.  The role of matrix metalloproteinases in autoimmune damage to the central and peripheral nervous system , 2000, Journal of Neuroimmunology.

[10]  V. Yong,et al.  Interleukin‐1 is a key regulator of matrix metalloproteinase‐9 expression in human neurons in culture and following mouse brain trauma in vivo , 2000, Journal of neuroscience research.

[11]  J. Mcculloch,et al.  Quantitative Assessment of Ischemic Pathology in Axons, Oligodendrocytes, and Neurons: Attenuation of Damage after Transient Ischemia , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[12]  G. Davies-Jones,et al.  Dexamethasone regulation of matrix metalloproteinase expression in CNS vascular endothelium. , 2000, Brain : a journal of neurology.

[13]  E. Lo,et al.  Reduction of Tissue Plasminogen Activator-Induced Hemorrhage and Brain Injury by Free Radical Spin Trapping after Embolic Focal Cerebral Ischemia in Rats , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[14]  M. Fujimura,et al.  Overexpression of Copper and Zinc Superoxide Dismutase in Transgenic Mice Prevents the Induction and Activation of Matrix Metalloproteinases after Cold Injury-Induced Brain Trauma , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[15]  T. Hibi,et al.  Risk-adapted pre-emptive therapy for cytomegalovirus disease in patients undergoing allogeneic bone marrow transplantation , 2000, Bone Marrow Transplantation.

[16]  J. Wettstein,et al.  White matter ischaemia , 1999, Brain Research Reviews.

[17]  K. Frei,et al.  Occludin proteolysis and increased permeability in endothelial cells through tyrosine phosphatase inhibition. , 1999, Journal of cell science.

[18]  Z. Werb,et al.  Matrix Metalloproteinase-9/Gelatinase B Is Required for Process Outgrowth by Oligodendrocytes , 1999, The Journal of Neuroscience.

[19]  M. Fujimura,et al.  Early Appearance of Activated Matrix Metalloproteinase-9 after Focal Cerebral Ischemia in Mice: A Possible Role in Blood—Brain Barrier Dysfunction , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[20]  M. Chopp,et al.  Endogenous plasminogen activator expression after embolic focal cerebral ischemia in mice , 1999, Brain Research.

[21]  T. Seifert,et al.  Differential expression of matrix metalloproteinases in bacterial meningitis. , 1999, Brain : a journal of neurology.

[22]  J. Koziol,et al.  Matrix Metalloproteinases Increase Very Early during Experimental Focal Cerebral Ischemia , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[23]  D. Ribatti,et al.  Developmental expression of ZO-1 antigen in the mouse blood-brain barrier. , 1999, Brain research. Developmental brain research.

[24]  J. Westermarck,et al.  Regulation of matrix metalloproteinase expression in tumor invasion , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[25]  K. Hossmann,et al.  Regional Metabolic Disturbances and Cerebrovascular Anatomy after Permanent Middle Cerebral Artery Occlusion in C57Black/6 and SV129 Mice , 1999, Neurobiology of Disease.

[26]  J B Schulz,et al.  Caspases as treatment targets in stroke and neurodegenerative diseases , 1999, Annals of neurology.

[27]  M. Cuzner,et al.  Plasminogen activators and matrix metalloproteases, mediators of extracellular proteolysis in inflammatory demyelination of the central nervous system , 1999, Journal of Neuroimmunology.

[28]  G. Rosenberg,et al.  Matrix Metalloproteinases in Cerebrovascular Disease , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[29]  Z. Werb,et al.  ECM signalling: orchestrating cell behaviour and misbehaviour. , 1998, Trends in cell biology.

[30]  G. Rosenberg,et al.  Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain. , 1998, Stroke.

[31]  G. Rosenberg,et al.  Gelatinase B modulates selective opening of the blood-brain barrier during inflammation. , 1998, American journal of physiology. Regulatory, integrative and comparative physiology.

[32]  Gabriele Bergers,et al.  MMP-9/Gelatinase B Is a Key Regulator of Growth Plate Angiogenesis and Apoptosis of Hypertrophic Chondrocytes , 1998, Cell.

[33]  F. Barone,et al.  Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size. , 1998, Stroke.

[34]  Voon Wee Yong,et al.  Matrix metalloproteinases and diseases of the CNS , 1998, Trends in Neurosciences.

[35]  S. Lipton,et al.  Tissue plasminogen activator (tPA) increase neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice , 1998, Nature Medicine.

[36]  H. E. Wart,et al.  Substrate Specificity and Mechanisms of Substrate Recognition of the Matrix Metalloproteinases , 1998 .

[37]  M. Fini,et al.  Regulation of Matrix Metalloproteinase Gene Expression , 1998 .

[38]  S. Nigam,et al.  Molecular structure and assembly of the tight junction. , 1998, American journal of physiology. Renal physiology.

[39]  S. Strickland,et al.  Neuronal Death in the Hippocampus Is Promoted by Plasmin-Catalyzed Degradation of Laminin , 1997, Cell.

[40]  L. Houenou,et al.  The role of thrombin-like (serine) proteases in the development, plasticity and pathology of the nervous system , 1997, Brain Research Reviews.

[41]  S. Tsirka,et al.  Neuronal death in the central nervous system demonstrates a non-fibrin substrate for plasmin. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[42]  G. Rosenberg,et al.  Metalloproteinase inhibition blocks edema in intracerebral hemorrhage in the rat , 1997, Neurology.

[43]  S. Tsirka,et al.  An Extracellular Proteolytic Cascade Promotes Neuronal Degeneration in the Mouse Hippocampus , 1997, The Journal of Neuroscience.

[44]  Gary A. Rosenberg,et al.  Proteolytic Cascade Enzymes Increase in Focal Cerebral Ischemia in Rat , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[45]  A. Dayton The Rev Axis of HIV-1 and Its Associated Host Cofactors: A Viral Window onto the Workings of Eukaryotic Posttranscriptional RNA Processing. , 1996, Journal of biomedical science.

[46]  P. Gottschall,et al.  Regulation of matrix metalloproteinase expressions in astrocytes, microglia and neurons. , 1996, Neuroimmunomodulation.

[47]  S. Chandler,et al.  Matrix metalloproteinases degrade myelin basic protein , 1995, Neuroscience Letters.

[48]  G. Hamann,et al.  Microvascular basal lamina antigens disappear during cerebral ischemia and reperfusion. , 1995, Stroke.

[49]  R. Bartus,et al.  Calpain as a novel target for treating acute neurodegenerative disorders. , 1995, Neurological research.

[50]  A. Campagnoni Molecular Biology of Myelin Proteins from the Central Nervous System , 1988, Journal of neurochemistry.

[51]  Osamu Uyama,et al.  Quantitative Evaluation of Vascular Permeability in the Gerbil Brain after Transient Ischemia Using Evans Blue Fluorescence , 1988, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[52]  F. Bloom,et al.  Splice site selection in the proteolipid protein (PLP) gene transcript and primary structure of the DM-20 protein of central nervous system myelin. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[53]  Z. Werb,et al.  Secretion of metalloproteinases by stimulated capillary endothelial cells. II. Expression of collagenase and stromelysin activities is regulated by endogenous inhibitors. , 1986, The Journal of biological chemistry.

[54]  P. Coyle,et al.  Dorsal cerebral arterial collaterals of the rat , 1982, The Anatomical record.